51 – 60 of 374
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Is immunotherapy the holy grail for pancreatic cancer?
- Contribution to journal › Debate/Note/Editorial
-
Mark
The role of PEDF in pancreatic cancer
- Contribution to journal › Scientific review
-
Mark
The hippo signaling pathway in pancreatic cancer
- Contribution to journal › Scientific review
-
Mark
Alpha-1-acid glycoprotein 1 is upregulated in pancreatic ductal adenocarcinoma and confers a poor prognosis
- Contribution to journal › Article
-
Mark
Early-onset pancreatic cancer : a population-based study using the SEER registry
- Contribution to journal › Article
-
Mark
Sustainability of an Enhanced Recovery Program for Pancreaticoduodenectomy with Pancreaticogastrostomy
- Contribution to journal › Article
-
Mark
Adjuvant therapy in invasive intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a systematic review
- Contribution to journal › Scientific review
-
Mark
Galectin 4 is a biomarker for early recurrence and death after surgical resection for pancreatic ductal adenocarcinoma
- Contribution to journal › Article
-
Mark
Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue
- Contribution to journal › Article
-
Mark
The Emerging Role of Calcium-activated Chloride Channel Regulator 1 in Cancer
- Contribution to journal › Scientific review
